Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...

But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...

Q4 2024 Earnings Call Transcript March 31, 2025 Brainstorm Cell Therapeutics Inc. reports earnings inline with expectations.

The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...

The new technology integrates active temperature regulation, precise optical path control, and a versatile form factor.

CEO of cell and gene therapy company Ori Biotech – and discussed in detail how the UK can compete with the US in biotech, if it focuses on tech. After all, the UK has all the right ingredients ...

With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

today announced it has acquired a majority interest in Aurion Biotech, Inc., a clinical-stage company developing advanced cell therapies to treat eye diseases. Aurion will operate as a separate ...

“Dr. Lacoste and the Aurion team have done tremendous work and their technology ... biotech in 2022. Aurion Biotech is advancing AURN001, an investigational single administration, allogeneic ...